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SHORT COMMUNICATION
Lactobacillus bulgaricus OLL1181 activates the aryl
hydrocarbon receptor pathway and inhibits colitis
Takeyuki Takamura1, Daisuke Harama1, Suguru Fukumoto1, Yuki Nakamura1, Naomi Shimokawa1,
Kayoko Ishimaru1, Shuji Ikegami2, Seiya Makino2, Masanori Kitamura3 and Atsuhito Nakao1
Increasing evidence suggests that the aryl hydrocarbon receptor (AhR) pathway has an important role in the regulation of
inﬂammatory responses. Most recently, we have shown that the activation of the AhR pathway by a potent AhR agonist inhibits
the development of dextran sodium sulfate (DSS)-induced colitis, a model of human ulcerative colitis, by the induction of
prostaglandin E2 (PGE2) in the large intestine. Because several strains of probiotic lactic acid bacteria have been reported to
inhibit DSS-induced colitis by unidentiﬁed mechanisms, we hypothesized that particular strains of lactic acid bacterium might
have the potential to activate the AhR pathway, thereby inhibiting DSS-induced colitis. This study investigated whether there
are speciﬁc lactic acid bacterial strains that can activate the AhR pathway, and if so, whether this AhR-activating potential
is associated with suppression of DSS-induced colitis. By using AhR signaling reporter cells, we found that Lactobacillus
bulgaricus OLL1181 had the potential to activate the AhR pathway. OLL1181 also induced the mRNA expression of cytochrome
P450 family 1A1 (CYP1A1), a target gene of the AhR pathway, in human colon cells, which was inhibited by the addition of an
AhR antagonist, a-naphthoﬂavon (aNF). In addition, mice treated orally with OLL1181 showed an increase in CYP1A1 mRNA
expression in the large intestine and amelioration of DSS-induced colitis. Thus, OLL1181 can induce activation of the intestinal
AhR pathway and inhibit DSS-induced colitis in mice. This strain of lactic acid bacterium has therefore the potential to activate
the AhR pathway, which may be able to suppress colitis.
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Aryl hydrocarbon receptor (AhR) recognizes numerous small xeno-
biotic and natural molecules, such as dioxin and various naturally
occurring chemicals, and is involved in the metabolism of these
compounds.1 Upon ligand binding, AhR in the cytosol translocates
to the nucleus, dimerizes with the AhR nuclear translocator, interacts
with the xenobiotic-responsive element (XRE) in the promoter
regions of target genes, and initiates the transcription of target
genes, such as the xenobiotic-metabolizing enzyme cytochrome
P450 1A1 (CYP1A1).1
AhR was ﬁrst discovered as a mediator of dioxin toxicity, but the
AhR pathway is now thought to have diverse physiological roles in
many different cellular functions.2,3 Recent studies also highlight AhR
as an important regulator of inﬂammation and immunity.4,5 For
instance, AhR inhibits the lipopolysaccharides signaling pathway
through an interaction with Stat1 in macrophages,6 suggesting that
AhR negatively regulates the lipopolysaccharides-induced inﬂamma-
tory response.
Dextran sodium sulfate (DSS)-induced colitis in rodents is
characterized by epithelial disruption, resulting in luminal bacterial
translocation and subsequent inﬁltration of neutrophils and other
acute immune cells.7 These features recapitulate the events that lead to
acute mucosal injury of human ulcerative colitis.7,8 We have previously
shown that activation of the AhR pathway inhibits DSS-induced colitis
in mice, possibly through induction of prostaglandin E2 (PGE2) in the
large intestine.9 These ﬁndings have prompted us to hypothesize that
environmental factors that can ameliorate DSS-induced colitis might
do so by activating the AhR pathway.
Probiotics, live commensal microorganisms that are beneﬁcial to
human and animal health, have been shown to be effective for
preventing or treating various diseases, including inﬂammatory
bowel diseases.10,11 Such health-promoting effects have been attrib-
uted to either the beneﬁcial effects on intestinal microbiota or to the
immunoregulatory effects of microbial components and metabolites,
or both.12 Previous studies have reported that several probiotic lactic
acid bacterial strains can inhibit DSS-induced colitis in rodents,13–15
although the precise mechanisms remain unclear.
The present study investigated whether there are speciﬁc lactic acid
bacterial strains that can activate the AhR pathway, and if so, whether
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induced colitis. We have previously established a speciﬁc and sensitive
in vitro bioassay for screening AhR-activating compounds in environ-
mental samples.16 Using this bioassay system, we screened a lactic acid
bacterial library kept at our facility for their AhR pathway-activating
potential, and then investigated whether such lactic acid bacterial
strains can inhibit DSS-induced colitis in mice.
RESULTS
Screening of lactic acid bacterial strains for stimulatory effects on
the AhR pathway
We screened 62 heat-killed lactic acid bacterial strains maintained by
our facility for their potential to activate the AhR pathway using an
in vitro bioassay system that we established previously.16 In brief, a
murine hepatoma cell line (Hepa-1c1c7) was stably transfected with a
secreted alkaline phosphatase (SEAP) gene under the control of the
XRE consensus sequences. The established sensor clone HeXS34
secreted SEAP following stimulation with 2,3,7,8-tetrachlorodi-
benzo-p-dioxin (TCDD) (positive control) or other chemicals that
can activate the AhR pathway. We found that 47 out of 62 (about
75%) heat-killed lactic acid bacterial strains, including L. bulgaricus
OLL1181 (see below), signiﬁcantly increased SEAP activity over
2-folds in the HeXS34 reporter cells (Supplementary Figure 1).
Heat-killed, but not live, lactic acid bacterial strains were used in
this study because proliferation of live bacteria can affect the bioassay,
thereby making the data from the bioassay not consistent.
L. bulgaricus OLL1181 can activate the AhR pathway in vitro
and in vivo
Because L. bulgaricus was one of the lactic acid bacteria, commonly
consumed as part of fermented foods, with specially added active live
cultures such as in yogurt, we focused on L. bulgaricus OLL1181 strain
for further experiments, and used Lactobacills gasseri MEP222701
(which induced minimal SEAP activity in HeXS34 cells) as a negative
control. OLL1181, but not MEP222701, increased the SEAP activity in
HeXS34 cells, and this increase in activity was inhibited by the
addition of an AhR antagonist a-naphthoﬂavone (aNF) (Figures 1a
and b). In the human colonic epithelial cell line, Caco2, OLL1181 also
signiﬁcantly induced CYP1A1 mRNA expression, which was again
inhibited by the addition of aNF (Figure 1c). In addition, mice treated
orally with one single-dose of OLL1181, but not MEP222701, demon-
strated the induction of CYP1A1 mRNA expression in the large
intestine (Figure 1d). The increase in CYP1A1 mRNA in the large
intestine showed peak at 1–2h and gradually lost thereafter following
the treatment with OLL1181 (Figure 1e). These results suggest that
OLL1181, but not MEP222701, can activate the intestinal AhR
pathway both in vitro and in vivo.
L. bulgaricus OLL1181 increases PGE2 production by Caco2 cells
Because TCDD, a potent AhR activator, induced PGE2 production in
Caco2 cells,9 we examined the effects of OLL1181 on PGE2 produc-
tion in Caco2 cells. OLL1181, but not MEP222701, induced PGE2
production in Caco2 cells, which was inhibited by the addition of aNF
(Figure 1f). We also found that OLL1181, but not MEP222701,
induced the mRNA expression of cyclooxgenase 2 (COX2), which is
a key enzyme involved in PGE2 production (Figure 1g).17 In addition,
mice treated orally with OLL1181 showed an increase in COX2 mRNA
expression in the large intestine (Figure 1h). These results suggest that
OLL1181 induced PGE2 production in Caco2 cells in an AhR path-
way-dependent manner, which was associated with increased COX2
expression.
L. bulgaricus OLL1181 ameliorates acute DSS-induced colitis
in mice
Finally, we examined the effects of OLL1181 on the development of
DSS-induced colitis in mice. The mice administered DSS that received
a vehicle control orally for 7 days exhibited an 80% mortality rate by
day 11 after DSS administration. The MEP222701-treated mice also
had an 80% mortality rate at 11 days after DSS. Conversely, OLL1181-
treated mice showed a marked increase in survival, with a 20%
mortality rate on day 11 after the administration of DSS
(Figure 2a). In addition, OLL1181 prevented DSS-induced colitis in
mice, as indicated by reduced body weight loss, increased colon length,
inﬂammatory scores and reduced tumor necrosis factor-a and mye-
loperoxidase expression in the large intestine compared with the
control (Figures 2b–e). These results suggest that OLL1181 can
ameliorate DSS-induced colitis in mice.
DISCUSSION
We ﬁrst screened a lactic acid bacterial library, kept at our facility, for
their AhR pathway-activating potential by the bioassay system we have
established before.16 The reliability of the bioassay to detect xenobiotic
AhR ligands has been extensively tested.16,18,19 This bioassay achieves
linear and dose-dependent responses, exclusively to agonists of the
AhR. Our observation that the OLL1181-induced increase in CYP1A1
mRNA expression was inhibited by an AhR antagonist (aNF) also
supports that OLL1181 has speciﬁc AhR-activating potential.
The components of OLL1181 that activate the AhR pathway remain
to be determined. Our screening data showed that about 75% of
lactic acid bacterial strains tested here have AhR-activating potential,
Figure 1 Lactobacillus bulgaricus OLL1181 induces activation of the AhR/XRE pathway both in vitro and in vivo.( a) HeXS34 cells were stimulated with
suspensions of heat-killed OLL1181 or MEP222701 (5 or 10%) for 24h. The activity of SEAP in the culture medium was evaluated by chemiluminescent
assay. (b) HeXS34 cells pretreated with or without a partial antagonist of the AhR, a-naphthoﬂavone (aNF; 10mM) were stimulated with suspensions of heat-
killed OLL1181 (10%) for 24h. The activity of SEAP in the culture medium was evaluated by chemiluminescent assay. (c) Caco2 cells pretreated with or
without 5mM aNF were stimulated with suspensions of heat-killed OLL1181 or MEP222701 (10%) for 4h. Real-time PCR was performed for detection of
CYP1A1 mRNA. (d) Mice were fed 200ml suspensions of heat-killed OLL1181, MEP222701 or phosphate-buffered saline. At 4h later, the large intestine of
each mouse was resected, and the mRNA expression level of CYP1A1 was examined by real-time PCR. (e)M i c ew e r ef e d2 0 0 ml suspensions of heat-killed
OLL1181 or PBS. The large intestine of each mouse was resected at the indicated times following the treatment and the mRNA expression level of CYP1A1
was examined by real-time PCR. (f) Caco2 cells pretreated with or without 10mM aNF were stimulated with suspensions of heat-killed OLL1181 or
MEP222701 for 24h. The PGE2 levels in the culture supernatants were measured by enzyme-linked immunosorbent assay. (g) Caco2 cells were stimulated
with suspensions of heat-killed OLL1181 or MEP222701 (10%) for 4h, then real-time PCR was performed to detect COX2 mRNA. (h) Mice were fed 200ml
suspensions of heat-killed OLL1181or phosphate-buffered saline. At 4h later, the large intestine of each mouse was resected, and the mRNA expressiono f
COX2 was examined by real-time PCR. The values represent the means±s.d. (n¼3 per group). *Po0.05 compared with the corresponding controls. Similar
results were obtained from two other independent experiments (a–g).
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across the lactic acid bacterial strains. AhR ligands have been generally
classiﬁed into two categories, synthetic or naturally occurring.20 The
ﬁrst ligands to be discovered were synthetic halogenated aromatic
hydrocarbons (dibenzodioxins and so on) and polycyclic aromatic
hydrocarbons (3-methylcholanthrene, benzo(a)pyrene and so on),
giving the receptor its name. Naturally occurring compounds that
have been identiﬁed as ligands of the AhR include derivatives of
tryptophan and arachidonic acid metabolites.21,22 Thus, it is possible
that such naturally occurring metabolites derived from OLL1181
or other probiotic strains are responsible for their AhR-activating
potential.
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Immunology and Cell BiologyWe previously showed that an artiﬁcial AhR agonist, TCDD,
induced PGE2 production in the mouse large intestine.9 However,
in the current study, we failed to show increased PGE2 production in
the large intestine of mice treated orally with OLL1181, (data not
shown) although we showed that there was an increase in the mRNA
expression of COX2, an enzyme involved in PGE2 production. The
differences in the results might be because of the different AhR-
agonistic activities of the two substances. TCDD has a very strong
AhR-activating potential with a half-life of 2 weeks in mice, whereas
OLL1181 has much lower AhR-activating potential compared with
TCDD, and its half-life in mice is unknown. We thus speculate that
OLL1181 might induce a weak PGE2 production in the mouse large
intestine (through the AhR pathway) that is under the threshold of
enzyme-linked immunosorbent assay detection, which can be attrib-
uted to the protection against DSS-induced colitis.
We found that one single-dose of oral OLL1181 treatment tran-
siently increased CYP1A1 mRNA in the mouse colon (Figure 1e) and
failed to inhibit DSS-induced colitis (Supplementary Figure 2). These
ﬁndings suggest that persistent, although weak, activation of the
intestinal AhR pathway obtained by daily administration of
OLL1181 might be necessary for the protection against DSS-induced
colitis.
OLL1181-treated mice showed a tendency to reduce body weight
more at days 4–6 during the DSS treatment than phosphate-buffered
saline-treated mice, although it was not statistically signiﬁcant
(Figure 2b). A previous study suggested that TCDD exposure was
associated with decreased survival, neutrophilia and elevated inter-
feron-g levels in the lungs following inﬂuenza virus infection,23
suggesting enhanced innate immune response by AhR activation.
Similar inﬂammatory events might occur at early time points in our
DSS-induced colitis model, but prolonged AhR activation by daily
OLL1181 treatment might increase production of protective factors
against intestinal injury such as PGE2 at later time points, thereby
ameliorating colitis. However, the precise mechanism(s) by which
Figure 2 Lactobacillus bulgaricus OLL1181 ameliorates acute DSS-induced colitis in mice. Mice administered a 3% DSS solution in drinking water for
7 days (days 1–8), followed by regular drinking water for an additional 3 days (days 8–11), were treated with phosphate-buffered saline, MEP222701, and
OLL1181 as described in the text. (a) Survival was monitored until day 11 after the start of DSS (n¼10–12 mice per group). (b) Body weight changes in
mice after the start of DSS (n¼4 mice per group). (c) Colon length in mice on day 11 (n¼4 mice per group). (d) Inﬂammation scores in mice on day 11
(n¼4 mice per group). (e) Real-time PCR for tumor necrosis factor-a and myeloperoxidase expression in the colon on day 11 (n¼4 mice per group).
The values represent the means±s.d. *Po0.05 compared with the corresponding controls. Similar results were obtained from two other independent
experiments (b–e).
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Immunology and Cell BiologyOLL1181 ameliorates DSS-induced colitis in mice remains to be
investigated.
In summary, we identiﬁed L. bulgaricus OLL1181 as a probiotic
bacterial strain that can activate the AhR pathway, leading to suppres-
sion of experimental colitis. To our knowledge, this is the ﬁrst study to
demonstrate that a particular lactic acid bacterial strain has AhR-
activating potential, and that this property might be linked to the
probiotic effects of lactobacilli.
METHODS
Microorganisms
Lactic acid bacterial strains maintained by our facility (Meiji Dairies, Kanagawa,
Japan) were cultured in Lactobacilli MRS broth (Becton Dickinson, Sparks,
MD, USA) at 371C for 18h. After fermentation, the cells were collected in a
refrigerated centrifuge (10000g, 15min) and washed twice with a saline
solution, followed by a wash with water. The cells were re-suspended in distilled
water (the cell counts were 5 109 colony forming units (CFU)ml 1,b a s e do n
a conventional assay on MRS broth plates containing 1.5% agar), heat-killed at
751C for 60min, and lyophilized.
Screening assay for AhR pathway activation
HeXS34 (Hepa-1c1c7–derived, pXRE-SEAP-transfected clone no. 34) cells were
established by transfection of Hepa-1c1c7 cells with pXRE-SEAP, which
introduces a SEAP gene under the control of two copies of the XRE consensus
sequence.16 The cells were maintained in MEMa (Invitrogen, Carlsbad, CA,
USA) supplemented with 10% fetal bovine serum. The reporter cells (5000/
90ml/well) were seeded in 96-well plates and cultured for 24h in the absence
(control) or in the presence of 10ml lyophilized heat-killed lactic acid bacterium
strains, unless speciﬁcally stated. The culture media of the reporter cells were
then subjected to chemiluminescent assay to evaluate SEAPactivity. To examine
the role of the AhR in the activation of XRE, HeXS34 cells were either left
untreated, or were pretreated with the indicated doses of aNF (an AhR
antagonist) for 30min. The media was then replaced with fresh media, and
then cells were exposed to heat-killed lactic acid bacterial strains. As a positive
control, cells were treated with 50pM TCDD.
SEAP assay
Activity of SEAP in conditioned media was evaluated by a chemiluminescent
method using the Great EscAPe SEAP detection kit (Clontech, Carlsbad, CA,
USA) as previously described.16 Assays were performed in triplicate unless
speciﬁcally stated otherwise.
Cell culture
The human Caco2 colonic adenocarcinoma cells were cultured in DMEM
(Invitrogen/Gibco, Mountain View, CA, USA) supplemented with 10% fetal
bovine serum in the presence of antibiotics at 371C in a humidiﬁed atmosphere
i nt h ep r e s e n c eo f5 %C O 2.
Quantitative real-time PCR
Quantitative PCR analysis of cDNAwas performed using an ABI 7300 real-time
PCR system (Applied Biosystems, Foster City, CA, USA) according to the
manufacturer’s instructions using primers and probes for mouse or human
CYP1A1, COX2, tumor necrosis factor-a, myeloperoxidase and glyceraldehyde-
3-phosphate dehydrogenase (Applied Biosystems) as previously described.24
The ratio of each gene to that of glyceraldehyde-3-phosphate dehydrogenase
was calculated, and the relative expression levels are shown.
PGE2 enzyme-linked immunosorbent assay
The amounts of secreted PGE2 were determined using a PGE2 Competitive
ELISA kit (Thermo Scientiﬁc, Waltham, MA, USA) according to the manu-
facturer’s instructions.
Induction of colitis
Female 4 to 6-week-old C57BL/6 mice were purchased from Japan SLC (Tokyo,
Japan) and were bred under speciﬁc pathogen-free conditions. To induce
colitis, mice were treated daily with 3% DSS (MW, 5000; Wako Pure Chemical,
Osaka, Japan) dissolved in distilled drinking water for 7 days, followed by
distilled water (no DSS) for 3 days, as previously described.9,25 To assess the
preventive effects of the bacterial strains, the mice were fed daily with a 200ml
suspension (1 109 CFU) of heat-killed lactic acid bacteria (OLL1181 and
MEP222701) for the ﬁrst 7 days by gastric lavage. Control mice were fed 200ml
phosphate-buffered saline daily for the ﬁrst 7 days. For some experiments, mice
were fed a 200mls u s p e n s i o n( 1  109 CFU) of heat-killed OLL1181 or
phosphate-buffered saline without DSS administration. The degree of inﬂam-
mation was histologically scored as previously described.25 Brieﬂy, scores of
inﬂammation were: 0, no increased inﬂammatory inﬁltrates; 1, focal mild
inﬂammation; 2, diffuse mild inﬂammation; 3, cryptic abscess formation; 4,
diffuse dense inﬂammation. All animal experiments were approved by the
Institutional Review Board of the University of Yamanashi.
Statistical analysis
The values represent the means±s.d. The statistical analysis was performed
using unpaired Student’s t-tests. A value of Po0.05 was considered to be
signiﬁcant.
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